Chembio Diagnostics Inc (CEMI.OQ)
CEMI.OQ on NASDAQ Stock Exchange Capital Market
7.85USD
19 Apr 2018
7.85USD
19 Apr 2018
Change (% chg)
$-0.20 (-2.48%)
$-0.20 (-2.48%)
Prev Close
$8.05
$8.05
Open
$8.00
$8.00
Day's High
$8.00
$8.00
Day's Low
$7.80
$7.80
Volume
3,607
3,607
Avg. Vol
6,256
6,256
52-wk High
$9.20
$9.20
52-wk Low
$5.70
$5.70
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2017 | Dec '17 | 5.99 | -0.162 |
| Sep '17 | 7.59 | -0.047 | |
| Jun '17 | 4.11 | -0.177 | |
| Mar '17 | 6.33 | -0.132 | |
| FY 2016 | Dec '16 | 4.25 | -0.212 |
| Sep '16 | 3.75 | -0.192 | |
| Jun '16 | 3.27 | -0.863 | |
| Mar '16 | 6.60 | -0.032 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Jun-18 | 2 | 7.11 | 7.18 | 7.04 | -- |
| Quarter Ending Sep-18 | 2 | 9.29 | 9.57 | 9.01 | -- |
| Year Ending Dec-18 | 2 | 32.21 | 32.63 | 31.80 | 29.51 |
| Year Ending Dec-19 | 2 | 42.38 | 45.55 | 39.22 | -- |
| Earnings (per share) | |||||
| Quarter Ending Jun-18 | 2 | -0.09 | -0.07 | -0.12 | -- |
| Quarter Ending Sep-18 | 2 | -0.06 | -0.03 | -0.10 | -- |
| Year Ending Dec-18 | 2 | -0.38 | -0.30 | -0.47 | -0.13 |
| Year Ending Dec-19 | 2 | -0.07 | -0.02 | -0.12 | -- |
| LT Growth Rate (%) | 1 | 25.00 | 25.00 | 25.00 | 25.00 |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 30.95 | 32.74 | |
| P/E High - Last 5 Yrs. | 60.44 | 40.70 | 45.72 | |
| P/E Low - Last 5 Yrs. | 43.00 | 23.63 | 24.22 | |
| Beta | 1.19 | 0.89 | 0.88 | |
| Price to Sales (TTM) | 4.21 | 3.94 | 5.71 | |
| Price to Book (MRQ) | 5.03 | 4.80 | 5.37 | |
| Price to Tangible Book (MRQ) | 6.34 | 5.61 | 6.95 | |
| Price to Cash Flow (TTM) | -- | 22.91 | 23.32 | |
| % Owned Institutions | 31.32 | 1.21 | 2.17 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 1.56 | 1.50 | |
| Dividend Yield - 5 Year Avg | -- | 1.57 | 1.51 | |
| Dividend 5 Year Growth Rate | -- | 4.47 | 5.32 | |
| Payout Ratio(TTM) | -- | 45.35 | 43.29 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | 25.97 | 3.69 | 9.21 | |
| Sales (TTM) vs TTM 1 Yr. Ago | -12.91 | 4.83 | 5.69 | |
| Sales - 5 Yr. Growth Rate | -1.62 | 10.08 | 10.32 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | 79.54 | 16.36 | 19.36 | |
| EPS (TTM) vs TTM 1 Yr. Ago | 29.28 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 9.87 | 10.76 | |
| Capital Spending - 5 Yr. Growth Rate | -30.40 | 15.52 | 15.47 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | 2.37 | 2.12 | 2.19 |
| Current Ratio (MRQ) | 3.66 | 2.90 | 2.98 |
| LT Debt to Equity (MRQ) | 0.00 | 9.88 | 12.18 |
| Total Debt to Equity (MRQ) | 0.00 | 13.86 | 16.45 |
| Interest Coverage (TTM) | -- | 35.89 | 32.81 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | 47.30 | 54.81 | 54.44 | |
| Gross Margin - 5 Yr. Avg. | 42.30 | 52.15 | 52.20 | |
| EBITD Margin (TTM) | -39.01 | -- | -- | |
| EBITD - 5 Yr. Avg | -4.67 | 18.57 | 10.96 | |
| Operating Margin (TTM) | -46.24 | 14.36 | 4.73 | |
| Operating Margin - 5 Yr. Avg. | -8.18 | 14.52 | 6.40 | |
| Pre-Tax Margin (TTM) | -46.01 | 14.82 | 5.57 | |
| Pre-Tax Margin - 5 Yr. Avg. | -8.15 | 14.90 | 6.81 | |
| Net Profit Margin (TTM) | -46.01 | 11.08 | 1.87 | |
| Net Profit Margin - 5 Yr. Avg. | -12.33 | 11.20 | 3.09 | |
| Effective Tax Rate (TTM) | -- | 23.16 | 23.04 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 23.42 | 23.96 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 140,773 | 938,080,053 | 846,831,062 | |
| Net Income/Employee (TTM) | -64,768 | 110,368,379 | 99,616,205 | |
| Receivable Turnover (TTM) | 3.99 | 5.63 | 5.78 | |
| Inventory Turnover (TTM) | 2.29 | 2.59 | 3.35 | |
| Asset Turnover (TTM) | 1.14 | 0.95 | 0.92 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -52.56 | 11.40 | 10.95 | |
| Return on Assets - 5 Yr. Avg. | -14.58 | 12.91 | 12.31 | |
| Return on Investment (TTM) | -68.16 | 14.84 | 14.38 | |
| Return on Investment - 5 Yr. Avg. | -17.83 | 16.88 | 16.10 | |
| Return on Equity (TTM) | -69.09 | 16.34 | 16.07 | |
| Return on Equity - 5 Yr. Avg. | -17.86 | 17.98 | 17.39 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | -26.33 | -15.44 | -1.62 |
| EPS (TTM) % | -404.58 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Chembio Diagnostics Inc
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
- BRIEF-Chembio Diagnostics Q4 Loss Per Share $0.16
- BRIEF-Chembio Diagnostics Announces Pricing Of Its Public Offering Of Common Stock
- BRIEF-Chembio Diagnostics Announces Proposed Public Offering Of Common Stock
- BRIEF-Chembio Diagnostics Announces Major New Tender Win And Certain Preliminary 2017 Financial Results
- BRIEF-Chembio Diagnostics Appoints Neil Goldman As CFO
Institutional Holders
| % Shares Owned: | 31.69% |
| # of Holders: | 29 |
| Total Shares Held: | 4,487,782 |
| 3 Mo. Net Change: | 4,030 |
| # New Positions: | 2 |
| # Closed Positions: | 0 |
| # Increased Positions: | 3 |
| # Reduced Positions: | 0 |
| # Net Buyers: | 3 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.